Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma, , , , , , , , , and 3 other author(s). Cell Death & Differentiation, (October 2018)Phosphoprotein Patterns Predict Trametinib Responsiveness and Optimal Trametinib Sensitisation Strategies in Melanoma, , , , , , , , , and 3 other author(s). Cell Death & Differentiation, 26 (8): 1365-1378 (2019)TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma, , , , , , , , and . Cell Death & Differentiation, (March 2019)Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma, , , , and . BMC Cell Biology, 19 (1): 28 (December 2019)TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma, , , , , , , , and . Cell Death and Differentiation, 26 (12): 2520-2534 (2019)Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma, , , , and . BMC Cell Biology, (2018)Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death, , , , , and . Oncology research, 25 (9): 1489-1494 (2017)